We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 52

Merger control: gun jumping goes global

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • June 28 2010

Broadly defined, "gun jumping" refers to unlawful premerger coordination between the parties to an M&A transaction

A new front in the patent wars: CJEU asked for guidance on limits to injunctive relief

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • April 11 2013

The patent wars between large technology companies continue unabated. The Court of Justice of the European Union (CJEU) is set to provide guidance on

U.S. and European perspectives on patent exhaustion

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • April 9 2009

In a highly anticipated decision, the Supreme Court of the United States issued its unanimous opinion in Quanta Computer, Inc. v LG Electronics, Inc

International trade actions complicate global market for renewable energy businesses, particularly in the solar sector

  • McDermott Will & Emery
  • -
  • China, European Union, Global, USA
  • -
  • December 3 2012

As a result of several recent actions, developers of solar energy projects may face increased costs

An employer’s guide to implementing EU-compliant whistleblowing hotlines

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • August 23 2011

Under the Sarbanes-Oxley Act, companies listed on U.S. stock exchanges are required to establish a system, often called a “whistleblowing hotline,” for employees to internally report concerns over questionable auditing or accounting matters

Product and disease registries: planning for data protection

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • April 10 2007

Biopharmaceutical companies have now seen the power of post-market approval and observational registries

Navigating the evolving regulation and commercialization of stem cell research

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • March 22 2012

Interested parties that can successfully navigate the evolving regulation of stem cell research stand to gain significant scientific and commercial advantage

Mutual recognition agreement should benefit companies involved in U.S.-EU trade

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • May 23 2012

A recent agreement between the United States and the European Union will facilitate customs and security clearance procedures in trans-Atlantic trade involving "trusted" U.S. and EU importers and traders

EMEA and FDA focus on clinical research safety and enforcement

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • August 20 2009

Recent policy changes emphasize the need for sponsoring organizations to be even more vigilant in establishing, updating and monitoring their systems for compliance with clinical research requirements, whether conducted domestically or in a foreign locale

EU supports US plans for rules on deregistration from capital markets

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • February 16 2007

The European Commission has sent a letter to the US Securities and Exchange Commission (SEC) to express its support for the amendment of US rules concerning deregistration from US capital markets